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Factors Associated With the Clinical
Outcomes of the Osteochondral
Autograft Transfer System in
Osteochondral Lesions of the Talus
Second-Look Arthroscopic Evaluation
Yong Sang Kim,* MD, Eui Hyun Park,*y MD, Yong Chan Kim,* MD,
Yong Gon Koh,* MD, and Jin Woo Lee,z MD, PhD
Investigation performed at Yonsei Sarang Hospital, Seoul, Korea
Background: Identifying factors associated with the clinical outcomes of the osteochondral autograft transfer system would be
helpful for treating patients with an osteochondral lesion of the talus.
Purpose: To investigate the clinical and second-look arthroscopic results of the osteochondral autograft transfer system and to
identify the prognostic factors associated with this procedure.
Study Design: Case series; Level of evidence, 4.
Methods: The authors retrospectively evaluated 52 ankles that underwent osteochondral autograft transfer for a medial osteo-
chondral lesion of the talus. Second-look arthroscopies were performed at a mean of 13.1 months postoperatively. Clinical out-
comes were evaluated according to a visual analog scale (VAS) for pain, American Orthopaedic Foot and Ankle Society (AOFAS)
score, and the Tegner activity scale. Statistical analyses were performed to identify various prognostic factors associated with the
clinical outcomes.
Results: The mean VAS, AOFAS, and Tegner activity scale scores were all significantly improved from 6.9 6 0.9 to 3.3 6 1.4
(VAS), from 67.4 6 4.9 to 82.6 6 7.8 (AOFAS), and from 3.0 6 0.8 to 3.9 6 0.9 (Tegner; P\ .05). Regarding overall patient sat-
isfaction with the operation, 49 (95%) patients reported good to excellent results. Prognostic factors including the patient’s age,
sex, body mass index, duration of symptoms, defect size and depth, location of osteochondral lesion of the talus, and the exis-
tence of a subchondral cyst did not significantly influence clinical outcomes (P . .05), except for body mass index on the Tegner
activity scale score (P = .021). Significant differences were observed among clinical outcomes for second-look arthroscopy ac-
cording to the presence of soft tissue impingement and uncovered areas around the graft (P\ .05). The VAS and AOFAS score at
the last follow-up were significantly worse when the articular surface of the tibial plafond at the malleolar osteotomy site was
uneven (P = .031 and .012, respectively).
Conclusion: This study showed that the articular surface of the tibial plafond at the malleolar osteotomy site, soft tissue impinge-
ment, and uncovered areas around the graft were important factors affecting the clinical outcomes, as observed through second-
look arthroscopy. Therefore, surgeons should restore the articular surface accurately after the osteotomy, and more caution should
be taken to avoid soft tissue impingement and uncovered areas around the graft when performing osteochondral autograft transfer.
Keywords: osteochondral autograft transfer system; osteochondral lesions; talus; second-look arthroscopy
Osteochondral lesion of the talus (OLT) can be treated with
various operative methods, including marrow-inducing
reparative procedures, such as abrasion chondroplasty,
curettage, subchondral drilling, and debridement with
microfracture, as well as restorative procedures, such as
osteochondral grafting and chondrocyte transplanta-
tion.12,14,15,17,18 There are conflicting opinions as to which
of the various operative treatments are the better methods.
Marrow-inducing reparative procedures provide accept-
able clinical results over midterm follow-up periods but
often fail in the long-term because of biomechanical
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insufficiency of regenerative fibrocartilage and scar tissue
that result from these methods.3,24 Subsequently, osteo-
chondral lesions may not respond to these marrow-
inducing reparative procedures, and articular surfaces
may continue to deteriorate, leading to osteoarthritis.
The osteochondral autograft transfer system has been
used to replace articular defects with hyaline cartilage
attached to its subchondral plate to allow for bony integra-
tion of the graft within the lesion bed.33 Hence, biopsy sam-
ples obtained during second-look arthroscopy may provide
histological evidence for confirming the survival of chon-
drocytes within the transplanted hyaline cartilage.3,20
A number of studies assessing the effectiveness of
osteochondral autografts to treat OLT have been per-
formed.1,3,20,28,41Among the literature, several studies
have reported on the results of osteochondral autografts
using specialized MRI sequences.2,25,47 However, the
efficacy of magnetic resonance imaging (MRI) in terms
of assessing grafted cartilage quality has not been estab-
lished, and it has been suggested that arthroscopy may
better predict the quality of grafted cartilage.4,38 Never-
theless, studies on the osteochondral autograft transfer
system for treatment of OLT using second-look arthros-
copy have rarely been published.
The aims of this study were (1) to investigate the clinical
and second-look arthroscopic results of the osteochondral
autograft transfer system in treatment of OLT and (2) to
identify the prognostic factors associated with the osteo-
chondral autograft transfer system.
MATERIALS AND METHODS
Between July 2007 and January 2010, 62 consecutive
patients (69 ankles) with OLT were treated with the osteo-
chondral autograft transfer system. Indications for the
osteochondral autograft transfer system technique include
symptomatic osteochondral defects and focal osteonecrosis
combined with a limited cartilage defect. All patients had
a localized osteochondral lesion of the talus with symptoms
of ankle joint pain or functional limitations, despite a min-
imum of 3 months of nonoperative management. Patients
with arthritic change of their ankle joint or deformity of
the axis of the ankle on plain radiographs were excluded.
The preoperative range of motion of the ankle joints was
not restricted in all cases. Among these cases, 60 lesions
were located on the medial side and 9 were located on the lat-
eral side of the talus. Second-look arthroscopies were per-
formed at a mean of 13.1 months postoperatively (range,
10-17 months) in 52 of the 60 medial talar dome lesions.
These 52 ankles (48 patients) were included in this study.
Medial talar dome lesions were approached using a medial
malleolar osteotomy, and all second-look arthroscopies were
performed when the screws, which fixed the medial malleo-
lus, were removed. We explained the purpose of the second-
look arthroscopy (the evaluation of the grafted site and the
need of additional arthroscopic procedures such as debride-
ment, synovectomy, and adhesiolysis) to all patients before
surgery and received written consent. This study was
approved by the institutional review board of our hospital.
The average age of the patients was 48.2 years (range, 21-
67 years), and the mean follow-up period was 34.1 months
(range, 24-48 months). There were 34 men and 18 women.
The average preoperative body mass index (BMI) was 25.7
(range, 19.9-30.4), and the average duration of symptoms
was 20.4 weeks (range, 16-34 weeks). Among the patients,
there were no professional athletes, but all patients tended
to enjoy sports activities and experienced traumatic events
to their ankles during such activities before visiting our
hospital.
All patients were evaluated clinically and radiographi-
cally before surgery and as part of the follow-up. As a clin-
ical evaluation, a visual analog scale (VAS) for pain and
the American Orthopaedic Foot and Ankle Society
(AOFAS) ankle-hindfoot scale were used. The Tegner
activity scale45 was used to determine sporting and activity
levels. Although the Tegner activity scale was originally
used for the knee, it was designed to facilitate outcomes
research in sports medicine. Furthermore, patients rated
their overall satisfaction with the operation as excellent,
good, fair, or poor and were asked whether they would
undergo the procedure again.
At preoperative and follow-up examinations, we investi-
gated the osteotomy sites through plain radiographs. We
performed MRI to measure the size and location of lesions
and to evaluate any associated lesions (eg, subchondral
cyst) before surgery. To avoid potential bias, an indepen-
dent observer, who was a trained musculoskeletal radiolo-
gist uninvolved in the care of the patients and who was
blinded to the intention of this study, evaluated the MRI
films. The width and length of the defect area were mea-
sured with coronal, sagittal, and axial MRI scans, and
the largest dimension was selected. We reconfirmed the
defect size with a ruler intraoperatively, and the defect
size was calculated by the ellipse formula (Figure 1C).
We compared the size measurements (width, length, and
size) based on MRI with those determined intraopera-
tively, and a good correlation was found by linear regres-
sion analysis (r = 0.85, P\ .001).
Surgical Technique
The patient was placed in the supine position under spinal
anesthesia. A thigh tourniquet was used for hemostasis.
Diagnostic arthroscopy was performed to investigate the
sizes and shapes of the medial talar lesions, and medial
malleolar osteotomy was performed as described below. A
10-cm linear medial incision was made overlying the cen-
ter of the medial malleolus, parallel to the axis of tibia.
The oblique osteotomy was performed using a microsagittal
saw after exposing the medial malleolus. The apex and
direction of the osteotomy were determined according to
the size of the osteochondral lesion of the talus (Figure 2,
A-D). The osteotomized medial malleolus was then
reflected plantarward on the deltoid ligament to expose
the medial aspect of the talar dome.
After identifying the lesion, we trimmed the peripheral
rim of the lesion and measured its size (Figure 1). For the
osteochondral autograft transfer, the Osteochondral Auto-
graft Transfer System instrumentation set (Arthrex Inc,
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Naples, Florida) was used for the recipient site preparation
as well as for osteochondral plug harvest and transplanta-
tion. The diameters of the plug and recipient socket were
determined by measuring the size of the cartilage defect
with sizer/tamps. Under direct visualization through
a mini-arthrotomy, placed just lateral to the patellar ten-
don, an osteochondral plug was cored out from the lateral
edge of the lateral trochlea using a donor tube harvester.
A donor graft, slightly larger than the osteochondral
lesion, was obtained to ensure that the lesion was com-
pletely resected. The donor plug was delivered to the
recipient site and impacted flush with the surrounding
articular cartilage of the talus. In 22 cases, 2 donor plugs
were transplanted because of the large size of the osteo-
chondral lesions. Subchondral drilling was performed at
the uncovered site between the 2 impacted plugs (Figure
3A). Subsequently, the malleolus was returned to its orig-
inal position and fixed with compression using three or
four 4.0 cannulated screws (Figure 2B).
After the operation, a short leg splint was applied for 2
weeks, and after sutures were removed, a short leg non-
weightbearing cast was applied for 4 weeks. Patients
Figure 1. (A) Identification of the margin of osteochondral lesion was performed. (B, C) After the peripheral rim of the osteochon-
dral lesion was trimmed, the size of lesion was calculated by ellipse formula. (D) Appropriate grafts were inserted after calculating
the size.
Figure 2. (A, C) Schematic drawings of the oblique medial malleolar osteotomy. (B, D) Postoperative anteroposterior radiographs
of the ankle. The apex and direction of the osteotomy were determined according to the size of osteochondral lesion of the talus.
(E, G) Schematic drawings of the oblique medial malleolar osteotomy. (F, H) Postoperative anteroposterior radiographs of the
ankle. (E, F) If the articular surface of the tibial plafond at the malleolar osteotomy site was even, the apex of the osteotomy
site tended to be uneven (horizontal arrows). (G, H) If the apex of the osteotomy site was even, the articular surface of the tibial
plafond at the malleolar osteotomy site tended to be uneven (vertical arrows).
Vol. 40, No. 12, 2012 Clinical Outcomes of the Osteochondral Autograft Transfer System 2711
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began range of motion exercises of both active and passive
exercises to the ankle joint at 6 weeks after the operation.
Sports or high-impact activities were limited for at least 3
months. The cannulated screws were removed after radio-
logical and clinical confirmation of union of the osteotomy
site routinely after 12 months postoperatively. Second-
look arthroscopy was performed at that time, before
removal of the screws. Additional arthroscopic procedures
were performed if pathologic lesions in the ankle joint
were found during the second-look arthroscopy.
Statistical Analysis
Statistical analysis was performed using SPSS software ver-
sion 12.0.1 (SPSS Inc, Chicago, Illinois), with significance
defined as P\ .05. Descriptive statistics were calculated as
mean 6 standard deviation. The principal dependent varia-
bles of clinical outcomes were VAS, AOFAS score, and the
Tegner activity scale at the last follow-up. The paired t test
was conducted for evaluation of changes in preoperative
and last follow-up values, and the Wilcoxon signed rank
test was conducted for evaluation of changes in clinical
outcomes at the second-look arthroscopy and the last
follow-up. We analyzed the association of factors—patient
characteristics, variables of OLT (defect size and depth, loca-
tion of OLT, and existence of subchondral cyst), and variables
of surgical procedures— with clinical outcomes. Median val-
ues were used as standard values for dividing patients
according to age, BMI, duration of symptoms, and defect
size and depth of OLT. Differences between groups were ana-
lyzed using the Mann-Whitney U test or the Kruskal-Wallis
test for multiple comparisons.
RESULTS
Outcomes at Follow-up
Before the operation, the mean VAS score was 6.9 6 0.9,
the mean AOFAS score was 67.4 6 4.9, and the mean
Tegner activity scale score was 3.0 6 0.8. At the last
follow-up, the mean VAS, AOFAS, and Tegner activity
scale scores were all significantly improved to 3.3 6 1.4,
82.6 6 7.8, and 3.9 6 0.9 (P \ .05). Regarding overall
patient satisfaction with the operation, 32 patients
reported their satisfaction as excellent (62%), 17 good
(33%), and 3 fair (5%). None of the patients reported poor
satisfaction with the operation. All 48 patients stated
that they would be willing to undergo the same operation
for their 52 ankles again.
Associations Between Patient
Characteristics and Outcomes
We used the Mann-Whitney U test to assess the indepen-
dent effects of patient age, sex, BMI, and duration of symp-
toms on clinical outcomes (Table 1). Median values were
used as a standard for dividing patients according to age
(\48 or 48 years), BMI (\26.0 or 26.0), and duration
of symptoms (\20 or 20 weeks). All prognostic factors
including the patient’s age, sex, BMI, and duration of
symptoms did not exhibit significant influences on clinical
outcomes (P . .05), except for BMI on the Tegner activity
scale. There was a statistically significant association
between BMI less than 26.0 and higher Tegner activity
scale (P = .021).
Figure 3. (A) Two osteochondral plugs were impacted, and the subchondral drilling (arrow) was performed at the uncovered area
between the 2 impacted plugs. (B) On second-look arthroscopy, the uncovered area was filled with unstable fibrous cartilage.
(C, D) The congruent margin of graft (arrow) was noticed. (E) Two osteochondral plugs were impacted, and the uneven surface
(arrow) between the 2 impacted plugs was observed. (F) The incongruent margin of graft was noticed on second-look arthros-
copy. (G) Two osteochondral plugs were impacted, and the uncovered area (arrow) between the 2 impacted plugs was observed.
(H) The uncovered area (arrow) was still noticed on second-look arthroscopy.
2712 Kim et al The American Journal of Sports Medicine
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Associations Between Variables of Osteochondral
Lesions of the Talus and Outcomes
The mean defect size of OLT was 150.4 6 56.7 mm2 (range,
51.7-294.2 mm2), and the mean depth was 9.0 6 3.1 mm
(range, 4.2-17.6 mm). To analyze the association of the size,
depth, and location of the OLT with clinical outcomes, we
divided the patients according to defect size into large
(150 mm2) and small (\150 mm2) size groups and deep
(9 mm) and shallow (\9 mm) depth groups. Median values
were used as standard values for dividing the groups. For
locating the OLT, we divided the medial talar dome into 3
parts horizontally and demarcated anteromedial, centrome-
dial, and posteromedial areas. Regarding location of the
OLTs, 8 ankles had OLTs in the anteromedial area, 15
ankles in the centromedial area, and 29 ankles in the
posteromedial area. Subchondral cysts, investigated through
MRI, existed in 30 ankles. According to the Mann-WhitneyU
test, all variable factors including defect size, depth, location
of OLT, and the existence of a subchondral cyst did not signif-
icantly influence clinical outcomes (P . .05; Table 2).
Associations Between Variables of
Surgical Procedures and Outcomes
We retrospectively reviewed postoperative plain radiographs
and found that the articular surface of the tibial plafond and
the apex of the osteotomy site did not tend to be even at the
same time. That is to say, if the articular surface of the tibial
plafond at the malleolar osteotomy site was even, the apex of
the osteotomy site tended to be uneven, and, contrary to this,
if the apex of the osteotomy site was even, the articular sur-
face of the tibial plafond at the malleolar osteotomy site
tended to be uneven, in most cases (Figure 2, E-H). We
considered that this phenomenon might have occurred
because of compressive force delivered to the malleolus in
the process of fixation with screws. The articular surfaces
of the tibial plafond at the malleolar osteotomy site were
even in 39 ankles and uneven in 13 ankles. The second-
look arthroscopic findings at these sites are shown in Figure
4, A-D. The VAS and the AOFAS scores at the last follow-up
were significantly worse when the articular surface of the tib-
ial plafond at the malleolar osteotomy site was uneven (P =
.031, P = .012, respectively; Table 3). For osteochondral auto-
graft transfer, the grafted plugs were inserted as follows: sol-
itary 8-mm diameter plugs in 6 ankles, double 8-mm
diameter plugs in 11 ankles, 8- and 10-mm-diameter plugs
in 2 ankles, solitary 10-mm diameter plugs in 24 ankles,
and double 10-mm diameter plugs in 9 ankles. No associa-
tions were found between grafted plugs and clinical outcomes
(Table 3). In 10 cases, patients were treated with arthroscopic
microfracture for OLT as a first operation and then subse-
quently treated with osteochondral autograft transfer
because of persistent pain and unsatisfactory clinical out-
comes. In 14 cases, patients with chronic ankle instability
received a modified Brostro¨m operation along with the sur-
gery for OLT. There were no statistical differences observed
regarding whether previous arthroscopic microfracture or
an accompanied modified Brostro¨m operation was performed
or not (Table 3).
Second-Look Arthroscopic Findings
With the second-look arthroscopy, the original grafted plugs
were preserved very well in all cases. However, some path-
ologic lesions such as fibrous adhesion, synovitis, incongru-
ence of grafts, and uncovered area formed between plugs
were observed. Fibrous adhesion causing soft tissue
TABLE 1
Associations Between Patient Characteristics and Outcomesa
Final Follow-up
VAS AOFAS Tegner
Factor n Mean 6 SD P Mean 6 SD P Mean 6 SD P
Age, yb .088 .153 .621
\48 19 3.0 6 1.6 85.4 6 5.9 3.8 6 1.9
48 33 3.4 6 1.3 81.3 6 6.8 3.9 6 1.8
Sex .414 .512 .720
Male 34 3.3 6 1.9 81.9 6 7.5 3.7 6 1.4
Female 18 3.5 6 1.5 82.2 6 7.6 3.6 6 1.2
BMIb .392 .598 .021c
\26.0 30 3.3 6 1.6 82.5 6 8.5 4.0 6 0.7
26.0 22 3.4 6 1.5 83.2 6 6.8 3.4 6 0.8
Duration of symptoms, wkb .823 .780 .650
\20 28 3.4 6 1.5 81.5 6 7.4 3.8 6 0.7
20 24 3.3 6 1.2 81.7 6 7.2 3.6 6 0.9
aVAS, visual analog scale; AOFAS, American Orthopaedic Foot and Ankle Society ankle-hindfoot scale; Tegner, Tegner activity scale; SD,
standard deviation; BMI, body mass index.
bMedian values are used as standard values for dividing the groups.
cStatistically significantly difference, P\ .05.
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impingement in the anterior recess was observed in 15
ankles, and arthroscopic adhesiolysis and debridement of
the impinged soft tissue were performed during the
second-look arthroscopy (Figure 4, E and F). Significant dif-
ferences were observed for clinical outcomes at the second-
look arthroscopy according to the presence of soft tissue
impingement (P = .025, P = .005, P = .034, for the VAS,
AOFAS, and Tegner activity scale, respectively). After the
arthroscopic procedures, there were no significant differen-
ces in clinical outcomes at the last follow-up (P . .05; Table
4). Severe synovitis was observed in 16 ankles, and arthro-
scopic synovectomy was performed during the second-look
arthroscopy (Figure 4G). The mean VAS, AOFAS score,
and Tegner activity scale score were improved after the syn-
ovectomy during the second-look arthroscopy, but there
were no significant differences in clinical outcomes at the
TABLE 2
Associations Between Variables of Osteochondral Lesion of Talus and Outcomesa
Final Follow-up
VAS AOFAS Tegner
Factor n Mean 6 SD P Mean 6 SD P Mean 6 SD P
Defect size,b mm2 .690 .781 .590
\150 30 3.5 6 1.2 81.7 6 6.4 3.5 6 1.2
150 22 3.4 6 1.3 81.6 6 6.8 3.6 6 1.7
Depth,b mm .635 .640 .510
\9.0 29 3.3 6 1.5 82.1 6 7.3 3.8 6 0.9
9.0 33 3.5 6 1.4 80.6 6 7.9 3.7 6 1.0
Location .745 .416 .256
AM 8 3.2 6 1.6 85.3 6 6.8 4.1 6 0.9
CM 15 3.3 6 1.5 81.7 6 7.4 3.8 6 0.7
PM 29 3.5 6 1.7 81.1 6 7.5 3.6 6 0.8
Subchondral cyst .450 .275 .720
Existence 30 3.3 6 1.5 82.7 6 7.7 3.8 6 0.9
Nonexistence 22 3.5 6 1.1 80.4 6 7.8 3.7 6 0.8
aVAS, visual analog scale; AOFAS, American Orthopaedic Foot and Ankle Society ankle-hindfoot scale; Tegner, Tegner activity scale; SD,
standard deviation; AM, anteromedial; CM, centromedial; PM, posteromedial.
bMedian values are used as standard values for dividing the groups.
TABLE 3
Associations Between Variables of Surgical Procedures and Outcomesa
Final Follow-up
VAS AOFAS Tegner
Factor n Mean 6 SD P Mean 6 SD P Mean 6 SD P
ASTP .031b .012b .245
Even 39 3.2 6 1.2 83.7 6 1.37 3.9 6 0.6
Uneven 13 4.4 6 1.3 79.8 6 1.2 3.7 6 0.7
Graft type .350 .271 .528
Solitary 8-mm 6 2.2 6 1.1 86.5 6 8.9 4.1 6 1.0
Double 8-mm 11 3.2 6 1.6 82.5 6 9.3 3.5 6 0.8
8-mm, 10-mm 2 3.1 6 1.4 81.5 6 9.4 4.2 6 0.8
Solitary 10-mm 24 3.6 6 1.5 80.7 6 7.2 3.8 6 0.9
Double 10-mm 9 3.5 6 1.4 81.8 6 7.4 3.9 6 1.0
Previous microfracture .425 .441 .582
Performed 10 3.5 6 1.4 81.2 6 8.3 3.7 6 0.7
Not performed 42 3.3 6 1.6 83.5 6 7.6 3.5 6 0.6
Accompanied MBO .680 .883 .760
Performed 14 3.5 6 1.5 81.9 6 7.5 3.3 6 0.8
Not performed 38 3.6 6 1.4 82.1 6 7.6 3.5 6 0.6
aVAS, visual analog scale; AOFAS, American Orthopaedic Foot and Ankle Society ankle-hindfoot scale; Tegner, Tegner activity scale; SD,
standard deviation; ASTP, articular surface of tibial plafond at malleolar osteotomy site; MBO, modified Brostro¨m operation.
bStatistically significantly difference, P\ .05.
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second-look arthroscopy and the last follow-up (P . .05;
Table 4). The margins of the grafts were congruent in 42
ankles (Figure 3, C and D) and incongruent in 10 ankles.
In those 10 ankles, the incongruity of the margin originated
from an uneven surface between 2 impacted plugs (Figure 3,
E and F). There were no significant differences in clinical out-
comes at the second-look arthroscopy and the last follow-up
regarding whether the margin of the graft was congruent
or not (P . .05, respectively; Table 4). If an uncovered area
formed between plugs when 2 osteochondral plugs were
used to carry out the osteochondral autograft transfer, multi-
ple subchondral drilling was performed additionally in that
area (Figure 3A). Through the second-look arthroscopy, we
observed that these uncovered areas were filled with fibrous
cartilage (Figure 4H) or unstable fibrous cartilage (Figure
3B), or they still remained as a defect area (Figure 3, G
and H). There was a significant difference in clinical out-
comes at the second-look arthroscopy regarding whether an
uncovered area was present or not (Table 4). In these cases,
debridement and trimming of unstable fibrous cartilage as
well as additional microfractures were performed during
the second-look arthroscopy. However, there was still a signif-
icant difference in clinical outcomes at the last follow-up
according to the presence of an uncovered area after the
second-look arthroscopic procedures (Table 4).
DISCUSSION
A number of retrospective studies assessing the effective-
ness of osteochondral autograft transfer to treat OLT
have been performed.§ In these studies, various factors
involved with osteochondral autograft transfer, including
the amount of incorporated grafts; the dead space between
the cylindrical grafts, which became filled with fibrocarti-
lage; the integration of donor and recipient hyaline carti-
lage; the size and depth of the defect; the size of the
grafts; age; activity level; and reliability of the patient,
were reported.14,30,32 We retrospectively reviewed 48 con-
secutive patients (52 ankles) with medial OLT who under-
went osteochondral autograft transfer and identified
prognostic factors associated with the osteochondral auto-
graft transfer system using second-look arthroscopy. To
our knowledge, this is the first study to perform second-
look arthroscopy to evaluate osteochondral autograft
transfer for OLT.
The overall clinical outcomes of osteochondral autograft
transfer for the treatment of OLT have been reported as
good in the literature.2,28,48 Assenmacher et al2 reported
that the mean VAS score was significantly improved
from 7.7 to 3.1 (P \ .001) after arthroscopically assisted
autologous osteochondral transplantations, and the post-
operative average AOFAS score was 80.2. Kreuz et al28
had slightly better results after 4 years of follow-up in 35
patients, with AOFAS scores ranging from 87 to 94 in their
4 different groups. Valderrabano et al48 reported that the
mean VAS score significantly improved from 5.9 to 3.9
(P = .02), and the mean AOFAS score significantly
increased from 45.9 to 80.2 (P\ .0001) after knee-to-ankle
mosaicplasty. Imhoff et al25 reported significant increases
in AOFAS score (from 50 to 78; P\ .01) and Tegner score
(from 3.1 to 3.7; P\ .05) as well as a significant decrease in
the VAS (from 7.8 to 1.5; P \ .01) from preoperative to
postoperative. In our study, similar postoperative clinical
results were found. The mean VAS score significantly
improved from 6.9 to 3.3, the mean AOFAS score
Figure 4. (A) The articular surface of tibial plafond at the malleolar osteotomy site was even (vertical black arrow). (B) Second-
look arthroscopy revealed a well-healed surface of the osteotomy site (horizontal black arrow). (C) The articular surface of the
tibial plafond at the malleolar osteotomy site was uneven (vertical white arrow). (D) The articular surface of the osteotomy site
was filled with fibrous tissue (horizontal white arrow). (E) A fibrous adhesion causing the impingement in anterior recess (black
arrow) was noticed. (F) Adhesiolysis and debridement of impinged tissue were performed. (G) Severe synovitis was noticed.
(H) Fibrous cartilage (white arrow) was observed at the margin of the graft.
§References 1, 3, 14, 18, 20, 25, 28, 48.
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significantly increased from 67.4 to 82.6, and the mean
Tegner activity scale significantly increased from 3.0 to
3.9 (P\ .05, respectively).
Several recent studies have indicated that older patients
seem to do well with arthroscopic treatment for OLT,9,12,22
while several authors have reported less favorable outcomes
of marrow-inducing reparative procedures for the treatment
of OLT in older patients.10,17,27 Most of these studies used
an arbitrary age limit as a cutoff to define ‘‘older’’ patients.
However, Choi et al8 reported that older age was not an
independent predictor of clinical failure after arthroscopic
treatment for OLT after controlling for other prognostic fac-
tors. Regarding osteochondral autograft transfer for the
treatment of OLT, Gautier et al14 reported that there was
a statistically significant association between age less than
45 years and higher outcome scores (P = .0001). However,
in our study, patient age (\48 or 48 years) did not signif-
icantly influence clinical outcomes (P . .05). We considered
that long-term evaluations including multivariate analyses
are required to investigate the association between
a patient’s age and the clinical outcomes of the osteochon-
dral autograft transfer system.
In our study, we found that all prognostic factors includ-
ing the patient’s age, sex, BMI, and duration of symptoms
did not significantly influence clinical outcomes (P . .05),
except for BMI on Tegner activity scale score (Table 1). There
was a statistically significant association between BMI less
than 26.0 and higher Tegner activity scale (P = .021). We
considered that confounding factors, such as patient’s
lifestyle—refraining from sports activity—or donor site mor-
bidity, might influence clinical outcomes in obese patients.
A review of the literature revealed significant correla-
tions between defect size and clinical outcomes of arthro-
scopic treatment of OLT. Several authors suggested
arthroscopic treatment for osteochondral lesions smaller
than 150 mm2.9,10,17 However, there are no data available
for limits on the size of an OLT suitable for osteochondral
autograft transfer or for the maximal size in which fibro-
cartilaginous filling will give relief from pain and prevent
progression of the disease.14 Hangody et al19 reported
that the minimum size of OLT suitable for mosaicplasty
is 10 mm in diameter. In a case reported by Chang and
Lenczner,7 the size of the talar defect was 9 mm in diame-
ter. Gautier et al14 reported a size of OLT from 70 mm2 to
420 mm2 in their study. In our study, the mean defect size
of OLT was 150.4 6 56.7 mm2 (range, 51.7-294.2 mm2),
and there was no significant association between defect
size of OLT and clinical outcomes when we divided
patients according to defect size into large (150 mm2)
and small (\150 mm2) size groups (P . .05; Table 2).
The results of grafting based on the location of the
lesion have not been extensively investigated. Only 1 study
reported improved outcomes for medial compared with lat-
eral lesions.1 In our study, we divided the medial talar
dome into 3 parts horizontally (anteromedial, centrome-
dial, and posteromedial areas) and found no significant
association between location of OLT and clinical outcomes
(P . .05; Table 2).
OLTs associated with subchondral cysts have been trea-
ted with a variety of procedures. Some authors have
advised against the use of marrow stimulation alone in
the treatment of cystic lesions, based on the results of their
studies.12,42,43 Second-look arthroscopy after talar osteo-
chondral drilling has also shown irregular chondral surfa-
ces.16,26 Therefore, replacement of articular cartilage and
subchondral bone would provide normal hyaline cartilage
and strengthen the subchondral bone.21 However, there
is insufficient evidence in the literature to support the
TABLE 4
Associations Between Arthroscopic Findings and Outcomes at Second-Look Arthroscopy and Final Follow-upa
Second-Look Arthroscopy Final Follow-up
VAS AOFAS Tegner VAS AOFAS Tegner
Factor n Mean 6 SD P Mean 6 SD P Mean 6 SD P Mean 6 SD P Mean 6 SD P Mean 6 SD P
Adhesion .025b .005b .034b .531 .570 .380
Presentc 15 4.5 6 0.8 78.4 6 6.1 3.2 6 1.0 3.4 6 1.4 82.7 6 5.8 3.6 6 0.6
Absent 37 3.6 6 1.5 81.4 6 8.3 3.9 6 1.0 3.3 6 1.7 80.9 6 6.1 3.9 6 0.9
Synovitis .839 .143 .196 .670 .154 .160
Present 16 3.9 6 1.5 76.9 6 1.0 3.4 6 1.0 3.5 6 1.6 78.7 6 7.8 3.5 6 0.6
Absent 36 3.8 6 1.4 80.6 6 7.5 3.9 6 1.0 3.3 6 1.4 82.9 6 5.4 3.9 6 0.7
Surface of graft .071 .133 .300 .120 .159 .620
Congruent 42 3.1 6 1.4 80.2 6 8.0 3.8 6 1.0 2.5 6 1.2 82.5 6 7.4 3.8 6 0.8
Incongruent 10 4.0 6 1.3 76.0 6 9.9 3.4 6 1.1 3.3 6 1.4 78.0 6 9.5 3.6 6 0.6
Uncovered area .002b .001b .010b .045b .031b .026b
Present 14 4.8 6 1.6 72.1 6 8.0 3.1 6 0.9 4.2 6 1.6 77.5 6 8.2 3.3 6 0.8
Absent 38 3.5 6 1.1 82.1 6 6.9 4.0 6 1.0 3.1 6 1.3 83.9 6 6.8 4.0 6 0.7
aVAS, visual analog scale; AOFAS, American Orthopaedic Foot and Ankle Society ankle-hindfoot scale; Tegner, Tegner activity scale; SD,
standard deviation.
bStatistically significant difference, P\ .05 (Mann-Whitney U test).
cResults of the Wilcoxon signed-rank test show statistically significant difference in VAS, AOFAS, and Tegner scale scores, P = .005, .001,
.023, respectively.
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use of osteochondral autografts in the treatment of cystic
lesions. Scranton et al44 evaluated the use of osteochondral
autografts to treat cystic lesions and reported good results.
In our study, subchondral cysts existed in 30 ankles, and
the existence of subchondral cysts did not demonstrate signif-
icant influences on the clinical outcomes (P . .05; Table 2).
Access to the defect to permit insertion of the autograft
perpendicular to the articular surface often requires an
arthrotomy combined with a periarticularosteotomy.13,34,46
Although most of the articular surface can be exposed using
an appropriate osteotomy, 15% of the talus, comprising the
central portion of the dome, cannot be accessed perpendicu-
larly with any osteotomy.34 In our study, an oblique medial
malleolar osteotomy was performed to expose the medial
talar dome, and the apex and direction of the osteotomy
were determined according to the size of the OLT (Figure
2, A-D). When performing an oblique osteotomy, care must
be taken not to inflict damage at the articular surface of
the tibial plafond because damage to the weightbearing sur-
face may influence clinical outcomes. O’Loughlin et al35
reported that critical to the osteotomy is precise reduction
and fixation to avoid fibrous nonunion or malunion. Accurate
reduction of the malleolus is also important to reduce damage
at the articular surface of the tibial plafond (Figure 4, A-D).
In our study, VAS and AOFAS score at the last follow-up
were significantly worse when the articular surface of the tib-
ial plafond at the malleolar osteotomy site was uneven (P =
.031, P = .012, respectively; Table 3). As a technical point,
reduction of the articular surface of the tibial plafond at
the malleolar osteotomy site should be performed evenly,
although the apex of the osteotomy site is uneven (Figure
2, E-H). Predrilling in the medial malleolus before reflecting
it plantarward on the deltoid ligament may be helpful to
reduce the medial malleolus more accurately and easily at
the end of the procedure.46 At the last follow-up, we found
that an uneven apex at the osteotomy site became even as
the bony union progressed, but uneven articular surfaces of
the tibial plafond remained uneven (Figure 4, A-D).
Imhoff et al25 reported that patients who had prior dril-
ling of their OLT and received osteochondral autograft
transfer thereafter had significantly worse clinical scores
(the VAS, the AOFAS score, and the Tegner activity scale)
than patients who underwent osteochondral autograft
transfer as a first-line treatment (P = .001, .008, and
.005, respectively). They hypothesized that during drilling
of the OLT, thermal damage might occur and consequently
impair the incorporation of a second-line osteochondral
autograft transfer treatment. In our study, 10 patients
who had been treated with arthroscopic microfracture for
OLT as a first operation were subsequently treated with
osteochondral autograft transfer, and there were no statis-
tical differences observed in clinical outcomes (the VAS,
the AOFAS score, and the Tegner activity scale) regarding
whether previous arthroscopic microfracture was per-
formed or not (P = .419, .381, and .682, respectively; Table
3). Therefore, the osteochondral autograft transfer system
may be a useful treatment option as a secondary salvaging
procedure after a failed arthroscopic microfracture.
Persisting pain after an ankle surgery is often caused by
the development of intra-articular fibrous scars or
adhesion causing soft tissue impingement of the ankle
joint. Plain radiograph is valuable for the diagnosis of
bony impingement but not for soft tissue impingement.
MRI is helpful for identifying soft tissue impingement;
however, its use in diagnosing soft tissue impingement
lesions remains controversial.11,31,40 Nevertheless,
arthroscopy is an effective method for diagnosing and
treating soft tissue impingement of the ankle joint.6 In
the second-look arthroscopy of our study, a fibrous adhe-
sion causing soft tissue impingement in the anterior recess
was observed in 15 ankles, and arthroscopic adhesiolysis
and debridement of impinged soft tissue were performed
during the second-look arthroscopy (Figure 4, E and F).
The VAS, AOFAS score, and Tegner activity scale score
were improved after performing the arthroscopic proce-
dures. Before the second-look arthroscopy, significant dif-
ferences were observed in clinical outcomes according to
the presence of soft tissue impingement (P = .025, .005,
and .034 for the VAS, AOFAS score, and Tegner activity
scale, respectively), and after performing the arthroscopic
procedures, there were no significant differences in clinical
outcomes at the last follow-up (P . .05; Table 4). We dis-
cerned that second-look arthroscopy would be useful in
providing valuable prognostic information as well as treat-
ing such pathologic conditions.
An interesting finding was observed on the second-look
arthroscopy. The incongruity of the margin originating
from an uneven surface between 2 impacted plugs was
observed in 10 ankles (Figure 3, E and F). However, there
were no significant differences in clinical outcomes at the
second-look arthroscopy and the last follow-up regarding
whether the margin of graft was congruent or not (P .
.05; Table 4).
Several authors have reported that up to one third of
the total area of an osteochondral autograft will degener-
ate into reparative fibrocartilage because of damaged carti-
lage at the periphery of the graft, filling of gaps at the
interface of the graft and the walls of the defect, and chon-
drocyte death due to mechanical trauma of graft inser-
tion.5,23,36 In our study, we observed through the second-
look arthroscopy that uncovered areas were filled with
fibrous cartilage (Figure 4H), filled with unstable fibrous
cartilage (Figure 3B), or still remained as a defect area
(Figure 3, G and H). There was a significant difference in
clinical outcomes at the second-look arthroscopy with
regard to whether uncovered areas were present or not
(Table 4). This result highlights the critical importance of
careful matching of the size and shape of the autograft to
the defect to minimize the amount of fibrocartilage that
forms around the autograft.33
There were no complications in our study, including
nerve injury, infection, or delayed wound healing. Non-
union and delayed union of the osteotomy may occur at
a rate reported between 0% and 2%.1,3,14,19,28,46 Baltzer
and Arnold3 and Lee et al29 recommended that the fixation
be removed between 9 and 18 months after the osteotomy
regardless of pain or evidence of hardware failure. In our
study, cannulated screws were removed after radiologic
and clinical confirmation of union of the osteotomy site
routinely after 12 months postoperatively, and there was
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no nonunion or delayed union of the osteotomy site. In 13
ankles, the articular surface of the tibial plafond at the
malleolar osteotomy site was uneven, and the clinical out-
comes were significantly worse in those ankles at the last
follow-up. Therefore, surgeons should restore the articular
surface accurately after the osteotomy to avoid mismatch-
ing of the articular surface. Potential donor-site morbidity
at the knee after harvesting an osteochondral graft for the
talus has been discussed in the literature.37,39,48 However,
there was no donor-site morbidity in our study. In the cur-
rent study, postoperative symptoms—such as persistent
pain, pain on heavy exertion, patellar instability, giving
way, and difficulty kneeling or squatting—were observed
in obese patients. Paul et al37 reported poorer results in
patients with an increased BMI. These results were also
observed in our study: there was a statistically significant
association between BMI less than 26.0 and higher Tegner
activity scale (P = .021; Table 1).
We investigated the clinical and second-look arthro-
scopic results of the osteochondral autograft transfer sys-
tem in treatment of OLT and identified the prognostic
factors associated with the osteochondral autograft trans-
fer system through this study. However, there are a num-
ber of limitations. First, there was a small number of cases
and a relatively short duration of follow-up period. For
more accurate evaluation of the osteochondral autograft
transfer system for OLT, a prospective study and a larger
series of cases with a longer follow-up period are required.
Second, we limited the subjects of this study to patients
with medial OLT. Therefore, further evaluation including
lateral OLT is needed to support the results of this study.
Third, we used the VAS, AOFAS score, and the Tegner
activity scale to evaluate clinical outcomes. A new scoring
system for second-look arthroscopy correlated with clinical
outcomes, and power analysis is necessary to identify the
prognostic factors more precisely. Lastly, the second-look
arthroscopy was performed at 1 year postoperatively. It
is unknown how the grafted cartilage will behave over
time, and changes of influencing factors after the first
year cannot be predicted.
In conclusion, this study showed that the articular sur-
face of the tibial plafond at the malleolar osteotomy site,
soft tissue impingement, and uncovered areas around the
graft were important factors affecting the clinical out-
comes, as observed through second-look arthroscopy.
Therefore, surgeons should restore the articular surface
accurately following the osteotomy, and more caution
should be taken to avoid soft tissue impingement and
uncovered areas around the graft when performing osteo-
chondral autograft transfer.
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